5VLI
Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)
5VLI の概要
エントリーDOI | 10.2210/pdb5vli/pdb |
分子名称 | Hemagglutinin, Computationally designed peptide HB1.6928.2.3, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (9 entities in total) |
機能のキーワード | inhibitor, protein design, influenza, hemagglutinin, viral protein-de novo protein complex, viral protein/de novo protein |
由来する生物種 | Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) 詳細 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 63147.79 |
構造登録者 | |
主引用文献 | Chevalier, A.,Silva, D.A.,Rocklin, G.J.,Hicks, D.R.,Vergara, R.,Murapa, P.,Bernard, S.M.,Zhang, L.,Lam, K.H.,Yao, G.,Bahl, C.D.,Miyashita, S.I.,Goreshnik, I.,Fuller, J.T.,Koday, M.T.,Jenkins, C.M.,Colvin, T.,Carter, L.,Bohn, A.,Bryan, C.M.,Fernandez-Velasco, D.A.,Stewart, L.,Dong, M.,Huang, X.,Jin, R.,Wilson, I.A.,Fuller, D.H.,Baker, D. Massively parallel de novo protein design for targeted therapeutics. Nature, 550:74-79, 2017 Cited by PubMed: 28953867DOI: 10.1038/nature23912 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.799 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード